IL1B and colitis: T. halophilus administration significantly downregulated IL-1β levels in colitis mice (7.65 ± 1.35 pg/mL vs. 18.21 ± 3.01 pg/mL, p < 0.05) compared to untreated colitis mice (Figure 8A).